Follow-up strategies for patients diagnosed with neuroendocrine tumours after initial treatment should include:
Regular clinical assessment to monitor for disease recurrence or progression.
Personalised follow-up plans based on individual risk factors, tumour grade, and treatment received.
Use of appropriate imaging modalities at scheduled intervals to detect recurrence or metastases, tailored to tumour behaviour and patient factors.
Assessment and management of late effects of treatment, including endocrine dysfunction, neuropathy, or secondary tumours, with relevant specialist referrals as needed.
Provision of a written treatment summary to the patient and their primary care team, outlining risks of late effects and follow-up plans.
Encouragement of healthy lifestyle measures to reduce risks of complications such as stroke or secondary malignancies.
Access to psychosocial support and rehabilitation services to address quality of life and functional needs.
While specific neuroendocrine tumour follow-up guidelines are not detailed in the provided context, these principles align with UK NICE recommendations for follow-up of brain tumours and other cancers, emphasising personalised surveillance, management of late effects, and multidisciplinary care coordination NICE NG99,NICE NG52.